Berlex, Inc. has issued a letter reminding prescribers of hepatotoxicity associated with Betaseron [interferon--1b].

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1049, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Human Interferon- -1a (Rebif) vs Recombinant Interferon- -1b (Betaseron) in Healthy Volunteers: A Pharmacodynamic and Tolerability Study

By Buraglio M.

Clinical Drug Investigation, Vol. 18, Iss. 1, 1999-07 ,pp. : 27-34

Adis International

Access to resources Recommend Favorite

Amgen Inc. has issued a `Dear Health Care Professional' letter advising of important changes to the labelling for Aranesp

Reactions Weekly, Vol. 1, Iss. 1035, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Octapharma USA Inc. has issued a voluntary market withdrawal of selected lots of Octagam

Reactions Weekly, Vol. 1, Iss. 1317, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

NovoNordisk Canada Inc. has issued a voluntary recall of two lots of GlucaGen Hypokit glucagon injection

Reactions Weekly, Vol. 1, Iss. 1317, 2010-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Iovate Health Sciences International Inc., the Canadian importer of `Complete 7-Day Cleanse', has issued a nationwide recall

Reactions Weekly, Vol. 1, Iss. 1289, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite